1. Biofilm inhibition in oral pathogens by nanodiamonds
- Author
-
Tongtong Zhang, Zhiqin Chu, Tony K C Hui, Shanthini Kalimuthu, Feng Xu, Vidhyashree Rajasekar, Yau Chuen Yiu, and Prasanna Neelakantan
- Subjects
Mouth ,0303 health sciences ,Chemistry ,medicine.drug_class ,Antibiotics ,Biofilm inhibition ,Biomedical Engineering ,Biofilm ,Microbial Sensitivity Tests ,02 engineering and technology ,021001 nanoscience & nanotechnology ,Oral cavity ,Anti-Bacterial Agents ,Nanodiamonds ,Microbiology ,High resistance ,03 medical and health sciences ,Biofilms ,medicine ,General Materials Science ,Diamond nanoparticles ,0210 nano-technology ,030304 developmental biology ,Antibacterial agent - Abstract
Complex microbial communities, e.g., biofilms residing in our oral cavity, have recognized clinical significance, as they are typically the main cause for infections. Particularly, they show high resistance to conventional antibiotics, and alternatives including nanotechnology are being intensively explored nowadays to provide more efficient therapeutics. Diamond nanoparticles, namely, nanodiamonds (NDs) with many promising physico-chemical properties, have been demonstrated to work as an effective antibacterial agent against planktonic cells (free-floating state). However, little is known about the behaviors of NDs against biofilms (sessile state). In this study, we uncovered their role in inhibiting biofilm formation and their disrupting effect on preformed biofilms in several selected orally and systemically important organisms. The current findings will advance the mechanistic understanding of NDs on oral pathogens and might accelerate corresponding clinical translation.
- Published
- 2021